Home Why I'm Not Giving Up on This Tiny Biotech Stock
 

Keywords :   


Why I'm Not Giving Up on This Tiny Biotech Stock

2015-03-18 15:22:51| Biotech - Topix.net

Since reporting in November that its promising hepatitis C drug ACH-3102 helped clear the virus from 100% of patients in a small clinical trial, shares in Achillion Pharmaceuticals Sovaldi last year revolutionized hepatitis C treatment. Sovaldi cast aside reliance on side-affect-laden peginterferon and cut patient treatment times in half, to 12 weeks, all while delivering functional cure rates of 90% or more.

Tags: stock giving tiny biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »